# Fuzheng Yiliu-1010

> **NCT04459754** · PHASE2 · UNKNOWN · sponsor: **Guangdong Provincial Hospital of Traditional Chinese Medicine** · enrollment: 189 (estimated)

## Conditions studied

- Colorectal Cancer Stage II and III

## Interventions

- **DRUG:** Fuzheng Yiliu Formulation

## Key facts

- **NCT ID:** NCT04459754
- **Lead sponsor:** Guangdong Provincial Hospital of Traditional Chinese Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-29
- **Primary completion:** 2021-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 189 (ESTIMATED)
- **Last updated:** 2020-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04459754

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04459754, "Fuzheng Yiliu-1010". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04459754. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*